Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, double blind, multi-centre, placebo controlled study to evaluate the efficacy and safety of methoxyflurane (Penthrox(TM)) for the treatment of acute pain in patients presenting to an Emergency Department with minor trauma

Next Previous
Trial Profile

A randomised, double blind, multi-centre, placebo controlled study to evaluate the efficacy and safety of methoxyflurane (Penthrox(TM)) for the treatment of acute pain in patients presenting to an Emergency Department with minor trauma

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 15 Oct 2016

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Methoxyflurane (Primary)
  • Indications Acute pain; Musculoskeletal pain
  • Focus Registrational; Therapeutic Use
  • Acronyms STOP!
  • Sponsors Medical Developments International

    • Most Recent Events

    • 27 Aug 2016 Results of subgroup analysis (adult subgroup) published in the Advances in Therapy
    • 17 Jun 2015 New source identified and integrated (ClinicalTrial.gov: US National Institutes of Health)
    • 20 Oct 2012 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database record.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top